VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells.
Molekulargewicht:
449.57
Reinheit:
99.92%
CAS Nummer:
[228544-65-8]
Formel:
C25H27N3O3S
Target-Kategorie:
Acyltransferase
T23521
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten